Absci (ABSI) Net Margin (2020 - 2026)

Absci (ABSI) reported Net Margin of 13766.98% for Q1 2026, down 1153237.0% on a YoY basis from N/an in Q1 2025, and down 202.7% sequentially from 4548.0% in Q4 2025.

Absci (ABSI) Net Margin (2020 - 2026) Analysis & Trends

Absci (ABSI) has 7 years of Net Margin data on file, last reported at 13766.98% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin fell 1153237.0% year-over-year to 13766.98%; the trailing twelve-month figure through Mar 2026 stood at 6450.76% (down 421863.0% YoY), and the FY2025 full-year result was 4113.68%, down 183962.0% from the prior year.
  • Net Margin fell to 13766.98% in Q1 2026, from 4548.0% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 1237.66% in Q2 2023 to a low of 13766.98% in Q1 2026.
  • A 5-year average of 4754.04% and a median of 4358.35% in 2024 frame the typical range for Net Margin.
  • Across the five-year window, Net Margin soared 855594 bps in 2022 and slumped 1153237 bps in 2026, its largest moves.
  • Tracing ABSI's Net Margin over 5 years: stood at 5743.66% in 2022, then declined by 21 bps to 6965.98% in 2023, then jumped by 37 bps to 4358.35% in 2024, then decreased by 4 bps to 4548.0% in 2025, then sank by 203 bps to 13766.98% in 2026.
  • Business Quant data shows ABSI's Net Margin at 13766.98% in Q1 2026, 4548.0% in Q4 2025, and 7594.18% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Absci 1.23 Bn 1.11 Bn - -13,766.98%

Historic Data

Download Data
DateValue
Mar 31, 2026 -13,766.98%
Dec 31, 2025 -4,548.00%
Sep 30, 2025 -7,594.18%
Jun 30, 2025 -5,154.97%
Mar 31, 2025 -2,234.61%
Dec 31, 2024 -4,358.35%
Sep 30, 2024 -1,610.70%
Jun 30, 2024 -1,948.82%
Mar 31, 2024 -2,447.10%
Dec 31, 2023 -6,965.98%
Sep 30, 2023 -2,956.18%
Jun 30, 2023 -1,237.66%
Mar 31, 2023 -1,840.43%
Dec 31, 2022 -5,743.66%
Sep 30, 2022 -7,468.22%
Jun 30, 2022 -2,862.28%
Mar 31, 2022 -8,080.55%
Dec 31, 2021 1,171.06%
Sep 30, 2021 -16,024.16%
Jun 30, 2021 -5,802.88%